Post-market drug safety evidence sources: an analysis of FDA drug safety communications

Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1134-6. doi: 10.1002/pds.3317.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Approval
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Product Surveillance, Postmarketing*
  • Safety*
  • United States
  • United States Food and Drug Administration / standards*